Notice Number: NOT-GM-12-117
Key Dates
Release Date: December 18, 2012
Issued by
National Institute of General Medical Sciences (NIGMS)
Purpose
The purpose of this Notice is to clarify the page limits of the Commercialization Plan in PAR-09-220 "Innovations in Biomedical Computational Science and Technology Initiative (SBIR[R43/R44])".
An error in the funding opportunity announcement (FOA) led to confusion about page limits for the Commercialization Plan in Fast-Track applications.
The corrected language is as follows:
SBIR Fast-Track Applications
The Fast-Track application must present a Commercialization Plan (maximum 15 pages) that addresses specific points as described in the SF424 (R&R) SBIR/STTR Application Guide.
SBIR Fast-Track Applications
The Fast-Track application must present a Commercialization Plan (maximum 12 pages) that addresses specific points as described in the SF424 (R&R) SBIR/STTR Application Guide.
All other aspects of the FOA remain unchanged.
Inquiries
Please direct all inquiries to:
Peter M. Lyster, Ph.D.
National Institute of General Medical Sciences
Division of Biomedical Technology, Bioinformatics, and Computational Biology
Telephone: 301.451.6446
Email: lysterp@mail.nih.gov
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
NIH . . . Turning Discovery Into Health
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |